REQUEST A DEMO
Total
USD $0.00
Search more companies

Genfar S.A (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Genfar S.A Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Genfar S.A. is a Colombian company that was founded on August 18, 1967 and is dedicated to the development and production of medicines and products for human use and animal health, over-the-counter and with medical prescription. As a brand of affordable medicines for the Sanofi Group, Genfar brings the internationally recognized quality of the Sanofi Group to approximately 14 countries in Latin America through a complete and varied portfolio.

Headquarters
Avenida Carrera 68 # 17 - 64 - Zona Industrial Montevideo
Bogota D.C.; Bogota D.C; Postal Code: 0614

Contact Details: Purchase the Genfar S.A report to view the information.

Basic Information
Total Employees:
Purchase the Genfar S.A report to view the information.
Outstanding Shares:
Purchase the Genfar S.A report to view the information.
Registered Capital:
Purchase the Genfar S.A report to view the information.
Incorporation Date:
December 17, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Genfar S.A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
18.78%
Total operating revenue
18.46%
Operating profit (EBIT)
-2.54%
EBITDA
-1.82%
Net Profit (Loss) for the Period
-23.06%
Total assets
9.3%
Total equity
31.82%
Operating Profit Margin (ROS)
-3.4%
Net Profit Margin
-4.41%
Return on Equity (ROE)
-16.23%
Debt to Equity Ratio
-0.65%
Quick Ratio
0.39%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?